RNS Number:5654D
YM BioSciences Inc.
25 May 2006


YM BioSciences Inc. (the "Company")

The Company announces that 5,675,287 common shares have been issued as partial
vendor consideration in conjunction with the acquistion of Eximias
Pharmaceutical Corporation.  Application has been made for these shares to be
admitted to AIM.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEIIFIDEEIEFIR
Grafico Azioni YM Bio. Com Shs (LSE:YMBA)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di YM Bio. Com Shs
Grafico Azioni YM Bio. Com Shs (LSE:YMBA)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di YM Bio. Com Shs